Atlas Trials

Metabolic Effects of Subchronic Dopamine D2 Receptor Blockade by Antipsychotic Drugs in Healthy Humans

Clinical trial NCT00625170 · COMPLETED

Trial details

NCT number
NCT00625170
Sponsor
Leiden University Medical Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Insulin ResistanceDyslipidemia
Start date
2004-05-01
Primary completion
2004-12-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.